How can a patient currently on insulin lispro (Novolog) 10 U before each main meal (three times daily) and insulin glargine (Basaglar) 40 U once daily be switched to a premixed insulin 70/30 given twice daily?

Converting from Basal-Bolus to 70/30 Premixed Insulin

Start with 70/30 insulin at approximately 50 units before breakfast and 20 units before dinner, representing roughly 2/3 of the total daily dose (70 units) in the morning and 1/3 in the evening.

Conversion Rationale

The current regimen provides:

• Total daily insulin: 70 units (30 units Novolog + 40 units Basaglar)
• Basal component: 40 units (57% of total)
• Prandial component: 30 units (43% of total)

According to the 2025 ADA Standards of Care 1, when converting to a twice-daily premixed insulin plan from a basal-bolus regimen:

• Use the same total daily insulin dose initially (70 units)
• Distribute as 2/3 before breakfast and 1/3 before dinner
• This translates to approximately 47 units before breakfast and 23 units before dinner

Practical Starting Doses

I recommend rounding to:

• 50 units 70/30 before breakfast
• 20 units 70/30 before dinner

This provides 70 units total daily dose, maintaining the current insulin exposure while redistributing it into the premixed formulation's fixed 70% intermediate-acting/30% rapid-acting ratio.

Important Considerations and Titration

Initial Monitoring

• Expect different glycemic patterns: The 70/30 formulation provides both basal and prandial coverage with each injection, unlike the separated basal-bolus approach
• Monitor pre-lunch and pre-bedtime glucose closely, as these reflect the intermediate-acting component's peak effect
• Assess fasting glucose to evaluate overnight basal coverage from the dinner dose

Dose Adjustments

Per ADA guidelines 1:

• If A1C <8%: Consider reducing the total dose by 4 units or 10% (reduce to 45 units AM, 18 units PM)
• For hypoglycemia: Determine the cause; if unclear, reduce the corresponding dose by 10-20%
• Titrate each injection separately based on glucose patterns:
  • Adjust morning dose based on pre-dinner glucose
  • Adjust evening dose based on fasting glucose

Critical Pitfalls

Loss of Flexibility: Unlike the current regimen where prandial insulin can be adjusted meal-by-meal, 70/30 provides fixed ratios. The patient must:

• Eat consistent carbohydrates at breakfast and dinner
• Time injections immediately before meals (within 15 minutes)
• Cannot skip meals without risking hypoglycemia from the rapid-acting component

Lunch Coverage: The morning 70/30 dose provides intermediate-acting insulin that peaks around lunch, but no rapid-acting coverage for lunch. If the patient has significant postprandial glucose excursions at lunch:

• Consider adding back a small dose of rapid-acting insulin at lunch (4-10 units)
• Alternatively, shift to a three-times-daily premixed regimen if glycemic control is inadequate

Hypoglycemia Risk: Research demonstrates that premixed insulin regimens are associated with higher rates of hypoglycemia compared to basal insulin alone 2, though the evidence comparing premixed to full basal-bolus is mixed. The patient should be counseled on:

• Increased nocturnal hypoglycemia risk from the evening dose
• Need for consistent meal timing and carbohydrate intake

Alternative Consideration

The 2024 ADA guidelines 3 note that basal-bolus regimens offer greater flexibility for patients with irregular schedules. Before converting, consider whether:

• The patient has difficulty with multiple daily injections (justifying the switch)
• The patient can maintain consistent meal timing and carbohydrate intake (required for premixed insulin success)
• Adding a GLP-1 RA to the current basal insulin might be preferable to intensifying with premixed insulin, as this reduces hypoglycemia and weight gain

Monitoring Timeline

• Week 1-2: Daily fasting and pre-dinner glucose checks
• Week 2-4: Adjust doses by 2 units every 3 days based on glucose patterns 1
• Month 1: Check A1C if baseline was elevated; otherwise check at 3 months
• Ongoing: Titrate to achieve fasting glucose and pre-dinner glucose within target range

The conversion is straightforward mathematically, but success depends heavily on patient adherence to consistent meal timing and carbohydrate intake—factors that should be assessed before making this switch 4, 5.